MBX Capital III-A LP · CIK 2060060
MBX Capital III-A LP
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Mar 11, 2025
through Mar 11, 2025
through Mar 11, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $1,445,000
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $1,445,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Capsule 20, a series of MBX Capital Opportunities I LLC · CIK 2115859
- MBX Capital NYS SSBCI Fund, LP · CIK 2059842
- Neurofold Therapeutics Inc. · CIK 2145237
Form D filings (1)
-
0002060060-25-000001D · Mar 11, 2025 · Pooled Investment FundOffering: $1,445,000Sold: $1,445,000